TabCAT Brain Health Assessment in Primary Care

Part of paid clinical trials in Pasadena, California.

Sponsor
University of California, San Francisco
Study ID
NCT06090578
Status
Recruiting
Apply to this trial

Conditions

  • Dementia
  • Mild Cognitive Impairment

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • TabCAT Brain Health Assessment Clinical Pathway — OTHER
    Primary care providers concerned that their patients are exhibiting signs of cognitive decline will refer them to clinical associates who will then perform the TabCAT-BHA tablet-based test. The TabCAT-BHA paradigm comprises 7-10 minutes of tablet-based testing and an optional 3-minute self-administered informant survey captures behavioral symptoms and change from baseline. The results are available to the PCP in the EMR along with turnkey guidance to evaluate for reversible causes, identify and involve a care partner, make and disclose diagnosis, provide community and educational resources, and make medical referrals as appropriate. Nursing support is available to support the PCP in making the diagnosis and to consult to the family via telephone post-diagnosis to address immediate care needs.

Study Details

Efficient and user-friendly paradigms to detect cognitive impairment, including dementia are needed in primary care. The TabCAT Brain Health Assessment accurately detects cognitive impairment via an appealing tablet interface with automated scoring and EMR integration. This study will evaluate the effectiveness of the paradigm on detection rates and other brain health outcomes via a pragmatic cluster randomized trial in 26 Kaiser Southern California primary care clinics.

Key Dates

Start date
Jul 27, 2023
Status verified
Oct 2025
Primary completion
Dec 31, 2026
Completion
Dec 31, 2026

Study Design

Enrollment
180,000 participants (estimated)
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH

Arms

  • Experimental: TabCAT-Brain Health Assessment Clinical Pathway
    Primary care providers concerned that their patients are exhibiting signs of cognitive decline based on patient, informant (family), or provider concerns will refer them for a TabCAT-BHA assessment and follow-up care.
  • No Intervention: Usual Care Clinical Pathway
    Patients in the control practices will continue with usual care workflows.

Primary Outcome Measure

The rate of patients with at least one cognitive impairment diagnosis documented in the medical record by any primary care provider during the 12-month steady state period at the clinic. [ Time Frame: During the 12-month steady state period ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Kaiser Permanente Southern California Department of Research & EvaluationPasadenaCalifornia91101
Huong Q Nguyen, PhD
[email protected]
626-773-0873
Mayra Macias
[email protected]
626-344-6667

Find similar trials in Pasadena, CA

By research site
Kaiser Permanente Southern California Department of Research & Evaluation· Pasadena, CA

Related Studies